View Sample PDF

This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Additionally, this review examines industry challenges and potential threats to syringe and needle supplies manufacturers and makes strategic recommendations for boosting market share. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the general public for medically related uses. The disposable syringe market segments are identified as: 1) total reusable needle and syringe market; 2) total disposable needle and syringe market; 3) prefilled syringes; 4) safety syringes; 5) insulin injector pens; 6) needleless injectors; 7) vaccination injectors; 8) blood collection needles and syringes; 9) hypodermic needles and syringes market; 10) insulin needles and syringes market; 11) specialty needles and syringes market; and 12) needleless injector market.

1. 1. Introduction 4
2. 1.1 Statement of Report 4
3. 1.2 About This Report 4
4. 1.3 Scope of the Report 4
5. 1.4 Objectives 5
6. 1.5 Methodology 6
7. 1.6 Executive Summary 6
9. 2. Disposable Syringe Markets 7
10. 2.1 Overview 7
11. 2.2 Infection Control and Safety 9
12. 2.3 Hospital Consolidations Pressure Companies to Reduce Prices 13
13. 2.4 Needleless Injector Manufacturers Forge Strategic Alliances 13
14. 2.5 Technological Advancements in Disposable Syringes 13
16. 3. Syringe Market Segments 16
17. 3.1 Overview 16
18. 3.1.1 World Market 16
19. 3.1.2 U.S. Market 18
20. 3.2 Total Reusable Needle and Syringe Market 18
21. 3.3 Total Disposable Needle and Syringe Market 18
22. 3.3.1 Drivers of Safety Syringes 20
23. 3.3.2 Restraints to Safety Syringes 20
24. 3.4 Pre-filled Syringes 21
25. 3.5 Insulin Injector Pens 23
26. 3.6 Needleless Injectors 24
27. 3.7 Vaccination Injectors 25
28. 3.8 Needle and Syringe Market Trends 27
29. 3.8.1 Market Segments 27
30. 3.8.2 Customer Needs 27
31. 3.8.3 Competitor Analysis 28
32. 3.8.4 Target Markets for Specialty Syringes 31
33. 3.8.5 Third Party Reimbursement 31
34. 3.8.6 Regulation 31
35. 3.8.7 Drug Discovery Trends 32
36. 3.8.8 Demographic Shifts 32
37. 3.8.9 Managed Care Initiatives 32
38. 3.8.10 Growth in Home Healthcare 34
40. 4. Technology Development and Sterilization Methods 36
41. 4.1 Disposable Syringes 36
42. 4.1.1 Autodestruct Syringes 37
43. 4.1.2 SoloShot™ 37
44. 4.2 Monodose Syringes 38
45. 4.3 Pre-filled Syringes 39
46. 4.3.1 Features of Pre-filled Membrane Syringes 40
47. 4.3.1.1 Products in Pre-filled Syringes 42
48. 4.3.1.2 Compatibility of Drug Components 45
49. 4.3.1.3 Lyophilized Drugs and Powders 46
50. 4.3.1.4 Dual-chambered Syringes 46
51. 4.3.1.5 Pre-filled Diluent Syringes 47
52. 4.3.1.6 Needle Safety Devices for Pre-filled Syringes 47
53. 4.3.1.7 Sterility Maintenance 48
54. 4.3.2 Pen Syringes 49
55. 4.3.2.1 Technical Advances in Pens 50
56. 4.3.2.2 Advantages of Pens 51
57. 4.3.2.3 Pen Types and Styles 51
58. 4.3.2.4 Pre-filled Pens 51
59. 4.3.2.5 Reusable Pens 52
60. 4.3.2.6 Device Preparation 52
61. 4.3.2.7 Autopen 53
62. 4.3.2.8 Unifine Pentips 53
63. 4.3.3 Autoject 2 53
64. 4.4 Insulin Syringes 53
65. 4.5 Jet Injectors 57
66. 4.6 Insulin Pens 58
67. 4.7 Uniject™ Injection Device 60
68. 4.8 Microneedle 63
69. 4.9 Needle Free Injection 63
70. 4.9.1 Hypospray 64
71. 4.10 Glass Pre-fillable Syringes 64
72. 4.11 Retractable Syringe 64
73. 4.12 Ultrasafe Passive Delivery Systems 65
74. 4.13 Ultrasmall Syringes and Microsyringes 66
75. 4.14 Tip Lok® Syringes 66
76. 4.15 Product Profiles 66
77. 4.15.1 Gettig Guard™ 66
78. 4.15.2 Inviro SNAP! ® 66
79. 4.15.3 Maxxon Safety Syringe 67
80. 4.15.4 Monoject Magellan™ 67
81. 4.15.5 Needle-Pro 67
82. 4.15.6 Point Lok® 67
83. 4.15.7 SafetyGlide™ 68
84. 4.16 SC Injection Technology 68
86. 5. Business Trends 70
87. 5.1 Market Drivers 70
88. 5.2 Market Prospects 73
89. 5.3 Marketing and Distribution 73
90. 5.4 Competitive Landscape 74
91. 5.5 Business Developments 75
92. 5.6 Acquisitions and Partnerships 76
93. 5.7 Key Players 76
94. 5.7.1 Kendall 76
95. 5.7.2 Becton Dickinson 77
96. 5.7.3 C.R. Bard 77
97. 5.7.4 International Medication Systems 78
98. 5.7.5 Terumo Medical Corporation 79
100. 6. Future Technologies 80
101. 6.1 Thermostable Vaccines and Vaccine Vial Monitors 80
102. 6.2 Sugar Glass 80
103. 6.3 Issues in Technology Transfer for AD Syringes 82
105. 7. Regulatory Measures 84
106. 7.1 Safety Syringes in Europe 84
107. 7.2 Safety Syringe Regulations and Recommendations 85
108. 7.3 Reimbursement Outlook for Injectables 86
111. 8. Corporate Profiles 87
113. 9. Corporate Directory 126
115. Appendix 1: FDA Approved Syringe Manufacturers 136
116. Appendix 2: NAPPSI Primary and Secondary Prevention: Needlestick Safety Device List 143
117. Appendix 3: Ambulatory Care Services OSHA/Safety Device Listing 147
118. Appendix 4: Frequently Asked Questions for the Needlestick and Safety Prevention Act 156
121. INDEX OF FIGURES
123. Figure 3.1: U.S. Safety Needle and Syringe Market 19
124. Figure 6.1: Strategy of the "Sugar Project" 82
127. INDEX OF TABLES
129. Table 2.1: Global Market for Needles and Syringes, 2001-2010 8
130. Table 3.1: Global Market for Injection Devices by Category 16
131. Table 3.2: Worldwide Dollar Market for Needles and Syringes, 1996-2010 17
132. Table 3.3: Worldwide Unit Market for Needles and Syringes, 1996-2010 17
133. Table 3.4: U.S. Dollar Market for Needles and Syringes, 1999-2010 18
134. Table 3.5: Worldwide Disposable Needle and Syringe Market, 1998 2006 19
135. Table 3.6: Worldwide Market for Disposable Needles and Syringes by Region 19
136. Table 3.7: Worldwide Safety Syringe Unit Sales, 1998 2006 20
137. Table 3.8: Worldwide Safety Syringe Dollar Volume, 1998 2006 21
138. Table 3.9: Share of Worldwide Safety Syringes Market by Competitor 21
139. Table 3.10: Share of Worldwide Market for Safety Syringes by Region 21
140. Table 3.11: Worldwide Pre-filled Syringe Unit Sales, 1998 2010 22
141. Table 3.12: Worldwide Pre-filled Syringe Dollar Volume, 1998 2006 22
142. Table 3.13: Share of Worldwide Pre-filled Syringe Market by Competitor 22
143. Table 3.14: Share of Worldwide Market for Pre-filled Syringes by Region 22
144. Table 3.15: Worldwide Insulin Injector Pen Dollar Volume, 1998 2006 23
145. Table 3.16: Worldwide Market for Needle Free Injectable Drug Delivery Systems, 1996-2005 24
146. Table 3.17: Worldwide Needleless Injector Dollar Volume, 1998 2006 24
147. Table 3.18: Worldwide Vaccination Injector Unit Sales, 1998 2006 25
148. Table 3.19: Share of Worldwide Market for Vaccination Injectors by Region 25
149. Table 3.20: Worldwide Vaccination Injector Dollar Volume, 1998 2006 25
150. Table 3.21: Share of Worldwide Vaccination Injector Market by Competitor 25
151. Table 3.22: Summary of Strengths and Weaknesses of Available Syringes 31
152. Table 3.23: Annual Change Per Capita in Healthcare Spending and Gross Domestic Product, 1994 2004 35
153. Table 4.1: Injection Data Using Soloshot and Disposable Syringes 37
154. Table 4.2: Summary Data for Doses by Soloshot and Disposable Syringes 38
155. Table 4.3: Wastage Analysis (Per Vial Used) 38
156. Table 4.4: Important Injectable Drug Therapies Using Pre-filled Devices 39
157. Table 4.5: Region-wise Market of Pre-filled Syringes 43
158. Table 4.6: Worldwide Pre-filled Syringe Unit Sales, 1998 2006 44
159. Table 4.7: Worldwide Pre-filled Syringe Dollar Volume, 1998 2004 44
160. Table 4.8: Insulin Delivery Systems Percent Retail Market Share 54
161. Table 4.9: Insulin Delivery Systems Percent Retail Market Share by Company 54
162. Table 4.10: Commonly-Available Insulin Syringes 55
163. Table 4.11: Features of Available Insulin Pumps 56
164. Table 4.12: Features of Available Jet Injectors 57
165. Table 4.13: Currently Available Insulin Delivery Pens 59
166. Table 4.14: Summary of Clinical and Field Experience with the Uniject Device 61